Literature DB >> 14978694

Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation.

Brandon Hayes-Lattin1, Timothy J Seipel, Ken Gatter, Michael C Heinrich, Richard T Maziarz.   

Abstract

Differential diagnosis for anemia late after allogeneic stem cell transplantation is broad. In this report, we describe a case of severe anemia secondary to pure red cell aplasia associated with human parvovirus B19 infection over 8 years after allogeneic bone marrow transplantation. Characteristics of parvovirus B19 infection and the immunosuppressed state after allogeneic stem cell transplantation are reviewed. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14978694     DOI: 10.1002/ajh.10474

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Acquired Pure Red Cell Aplasia caused by Parvovirus B19 Infection following a Renal Transplant.

Authors:  Arundathi Kurukulasuriya; Amal A Hamed; Muhanna Al-Muslahi; Asaid Ibrahim
Journal:  Sultan Qaboos Univ Med J       Date:  2011-05-15

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.

Authors:  Georg Stussi; Jörg Halter; Eveline Bucheli; Piero V Valli; Lutz Seebach; Jürg Gmür; Alois Gratwohl; Urs Schanz; Jakob R Passweg; Jörg D Seebach
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

Review 4.  Human bocavirus: passenger or pathogen in acute respiratory tract infections?

Authors:  Oliver Schildgen; Andreas Müller; Tobias Allander; Ian M Mackay; Sebastian Völz; Bernd Kupfer; Arne Simon
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

5.  High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy.

Authors:  Thomas Schenk; Martin Enders; Stefan Pollak; Ralph Hahn; Daniela Huzly
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

6.  Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients.

Authors:  Bianca E Gama; Vanessa E Emmel; Michelle Oliveira-Silva; Luciana M Gutiyama; Leonardo Arcuri; Marta Colares; Rita de Cássia Tavares; Luis F Bouzas; Eliana Abdelhay; Rocio Hassan
Journal:  Transplant Direct       Date:  2017-10-02

7.  Investigation of epstein-barr virus and parvovirus b19 DNA in allogeneic stem cell transplant patients.

Authors:  Altay Atalay; Selma Gökahmetoğlu; Süleyman Durmaz; Idris Kandemir; Derya Sağlam; Leylagül Kaynar; Bülent Eser; Mustafa Cetin; Hüseyin Kılıç
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.